1. Home
  2. GTIM vs KTTA Comparison

GTIM vs KTTA Comparison

Compare GTIM & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Good Times Restaurants Inc.

GTIM

Good Times Restaurants Inc.

N/A

Current Price

$1.28

Market Cap

14.7M

ML Signal

N/A

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

N/A

Current Price

$0.38

Market Cap

15.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GTIM
KTTA
Founded
1987
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
15.6M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
GTIM
KTTA
Price
$1.28
$0.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.2K
★ 282.6K
Earning Date
08-06-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 77.07
EPS
★ 0.21
N/A
Revenue
★ $142,315,000.00
$486,559.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.10
★ N/A
Revenue Growth
3.01
★ 3130.37
52 Week Low
$1.10
$0.28
52 Week High
$1.66
$2.06

Technical Indicators

Market Signals
Indicator
GTIM
KTTA
Relative Strength Index (RSI) 32.31 33.69
Support Level $1.14 $0.36
Resistance Level $1.34 $0.52
Average True Range (ATR) 0.06 0.05
MACD -0.00 -0.00
Stochastic Oscillator 27.27 14.56

Price Performance

Historical Comparison
GTIM
KTTA

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants, which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants, which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers, chicken, frozen custard; slides and drinks.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Share on Social Networks: